Stocktwits on MSN10h
Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline
Shares of Leap Therapeutics, Inc. nosedived more than 70% to an all-time low on Tuesday, making them the top loser across U.S ...
Medpage Today on MSN2d
Combination Slows Metastatic CRC Progression Better Than Single Immunotherapy
An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression ...
CRC Approves California's First Carbon Capture and Storage Project
Project approval follows CRC’s recent receipt of final Class VI well permits from the Environmental Protection Agency (EPA) for underground injection and storage of carbon dioxide (CO 2) into the 26R ...
Mainz Biomed Moves Forward With Pivotal CRC Study After Feasibility Trial
Mainz Biomed NV (MYNZ), a molecular genetics diagnostic company, on Tuesday announced the launch of the eAArly DETECT 2 feasibility ...
oncnursingnews3d
Bevacizumab’s Benefit in Colorectal Cancer May Be Limited to 2 Years Post-Administration
The 2-year benefit of bevacizumab in colorectal cancer may explain why survival benefits are seen in studies with two-year, ...